[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100590761":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":28,"centralContacts":41,"locations":49,"responsibleParty":64,"collaborators":24,"id":67,"slug":24,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":24,"eligibilityCriteria":72,"healthyVolunteers":68,"sex":73,"minAge":74,"maxAge":24,"enrollmentInfo":75,"targetDuration":24,"studyType":78,"phases":79,"briefSummary":81,"conditions":82,"keywords":87,"overallStatus":51,"whyStopped":24,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"Istanbul University - Cerrahpasa","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention Group","EXPERIMENTAL","Participants in the intervention group will be included in a structured telehealth monitoring program led by a nurse for 12 weeks.",[13],"Behavioral: Nurse-led Telehealth Monitoring Program",{"label":15,"type":6,"description":16,"interventionNames":17},"Control group","Participants in the control group will only receive standard care. No additional interventions will be implemented during the 12-week period.",[18],"Other: No intervention",[20,25],{"type":21,"name":22,"description":11,"armGroupLabels":23,"otherNames":24},"BEHAVIORAL","Nurse-led Telehealth Monitoring Program",[9],null,{"type":6,"name":26,"description":16,"armGroupLabels":27,"otherNames":24},"No intervention",[15],[29,33,37],{"name":30,"affiliation":31,"role":32},"Kimya Kılıçaslan, PhD Candidate","Istanbul University - Cerrahpasa Institute of Graudate Studies","PRINCIPAL_INVESTIGATOR",{"name":34,"affiliation":35,"role":36},"Zeliha Tulek, PhD, Prof.","Istanbul University - Cerrahpasa, Florence Nightingale Faculty of Nursing","STUDY_DIRECTOR",{"name":38,"affiliation":39,"role":40},"Aykut Ferhat Çelik, MD, Prof.","Istanbul University - Cerrahpasa Cerrahpaşa Faculty of Medicine Department of Gastroenterology","STUDY_CHAIR",[42,46],{"name":30,"role":43,"phone":44,"phoneExt":24,"email":45},"CONTACT","+90 535 083 45 53","kimya.kilicaslan@iuc.edu.tr",{"name":34,"role":43,"phone":47,"phoneExt":24,"email":48},"+90 532 776 29 93","ztulek@iuc.edu.tr",[50],{"facility":39,"status":51,"city":52,"state":24,"zip":53,"country":54,"cosmosGeoPoint":55,"geoPoint":60,"contacts":61},"RECRUITING","Istanbul","34098","Turkey (Türkiye)",{"type":56,"coordinates":57},"Point",[58,59],28.94966,41.01384,{"lat":59,"lon":58},[62],{"name":63,"role":43,"phone":44,"phoneExt":24,"email":45},"Kimya Kılıçaslan, RN, PhD Candidate",{"type":32,"investigatorFullName":65,"investigatorTitle":66,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"Zeliha Tülek","RN, MSc, PhD, Prof.","100590761",false,"NCT06971627","Telehealth Monitoring in Inflammatory Bowel Disease: Effects on Medication Compliance, Self-Efficacy, and Quality of Life","The Effect of Telehealth Monitoring on Medication Compliance, Self-Efficacy and Quality of Life in Patients With İnflammatory Bowel Disease","Inclusion Criteria:\n\n* Individuals aged 18 years or older\n* Individuals aged 18 years or older\n* Able to read and write in Turkish\n* Diagnosed with inflammatory bowel disease (IBD) for at least 6 months\n* In clinical remission (Harvey-Bradshaw Index score \\\u003C 5 or Simple Clinical Colitis Activity Index score \\\u003C 3)\n* Able to use a smartphone\n* Have access to an online messaging application (e.g., WhatsApp) and a valid e-mail address\n* Capable of downloading and using a mobile or computer-based video conferencing application (e.g., Zoom)\n* Willing to participate in the study voluntarily\n\nExclusion Criteria:\n\n* Diagnosed with any psychiatric or cognitive disorder\n* Having any condition that impairs communication\n* Pregnant women\n* Patients receiving infusion-based treatment\n* Having an advanced chronic disease","ALL","18 Years",{"count":76,"type":77},120,"ESTIMATED","INTERVENTIONAL",[80],"NA","This randomized controlled trial aims to evaluate the effect of nurse-led telehealth monitoring on medication adherence, self-efficacy, and quality of life in individuals with inflammatory bowel disease (IBD). The study will be conducted at the IBD Outpatient Clinic of Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty. Participants will be randomly assigned to either an intervention group receiving a 3-month structured telehealth program (including education, counseling, phone calls, and reminders) or a control group receiving only standard care and an educational booklet. Outcomes will be assessed at baseline and after 12 weeks.",[83,84,85,86],"Inflammatory Bowel Disease (IBD)","Medication Compliance","Quality of Life","Telehealth Monitoring",[88,84,89,85,86,90,91],"Inflammatory Bowel Disease","Self-Efficacy","Crohn's Disease","Ulcerative colitis","2025-05-07",{"date":94,"type":95},"2025-05-14","ACTUAL",{"date":97,"type":95},"2024-04-20",{"date":99,"type":77},"2025-05-30",{"name":5,"class":6},1]